World's Best Scientists 2026 revealed!

D-Index & Metrics

Medicine

D-Index
78
Citations
21504
World Ranking
18074
National Ranking
602

Overview

Pierre Wolkenstein is affiliated with Assistance Publique - Hôpitaux de Paris in France. Their research primarily focuses on the field of Medicine, with a significant number of publications contributing to subfields such as Neurology, Rheumatology, Dermatology, Pathology and Forensic Medicine, and Pharmacology.

The main topics covered in their work include:

  • Neurofibromatosis and Schwannoma Cases
  • Drug-Induced Adverse Reactions
  • Autoimmune Bullous Skin Diseases
  • Soft tissue tumor case studies
  • Urticaria and Related Conditions
  • Contact Dermatitis and Allergies
  • Sarcoma Diagnosis and Treatment

Wolkenstein has published extensively in several scientific journals. Frequent venues for their work include:

  • Annales de Dermatologie et de Vénéréologie - FMC
  • Annales de Dermatologie et de Vénéréologie
  • Journal of the European Academy of Dermatology and Venereology
  • Journal of Investigative Dermatology
  • British Journal of Dermatology

Among their recent papers are

  • "Revised diagnostic criteria for neurofibromatosis type 1 and Legius syndrome: an international consensus recommendation" (2021), published in Genetics in Medicine
  • "Updated diagnostic criteria and nomenclature for neurofibromatosis type 2 and schwannomatosis: An international consensus recommendation" (2022), published in Genetics in Medicine
  • "Neurofibromatosis 1 French national guidelines based on an extensive literature review since 1966" (2020), published in Orphanet Journal of Rare Diseases
  • "Adverse events associated with JAK inhibitors in 126,815 reports from the WHO pharmacovigilance database" (2022), published in Scientific Reports
  • "Cancer Surveillance Guideline for individuals with PTEN hamartoma tumour syndrome" (2020), published in European Journal of Human Genetics

Collaborations have been an important aspect of Wolkenstein's research activity. Frequent coauthors include:

  • S. Oro
  • S. Ferkal
  • L. Fertitta
  • Christina Bergqvist
  • É. Sbidian

Best Publications

  • SCORTEN: A Severity-of-Illness Score for Toxic Epidermal Necrolysis

    Sylvie Bastuji-Garin;Nathalie Fouchard;M Bertocchi;Jean-Claude Roujeau

  • Prevalence and factors associated with hidradenitis suppurativa: Results from two case-control studies

    Jean E. Revuz;Florence Canoui-Poitrine;Pierre Wolkenstein;Cedric Viallette

  • Randomised comparison of thalidomide versus placebo in toxic epidermal necrolysis

    Pierre Wolkenstein;Jacques Latarjet;Jean-Claude Roujeau;Corinne Duguet

  • Toxic epidermal necrolysis: Effector cells are drug-specific cytotoxic T cells

    Amal Nassif;Armand Bensussan;Laurence Boumsell;Aurelien Deniaud

  • Quality of life impairment in hidradenitis suppurativa : A study of 61 cases

    Pierre Wolkenstein;Anderson Loundou;Karine Barrau;Pascal Auquier

  • Apoptosis as a mechanism of keratinocyte death in toxic epidermal necrolysis

    C. Paul;P. Wolkenstein;H. Adle;J. Wechsler

  • Severe cutaneous adverse reactions to drugs.

    Tu Anh Duong;Laurence Valeyrie-Allanore;Pierre Wolkenstein;Olivier Chosidow

  • Patch testing in severe cutaneous adverse drug reactions, including Stevens‐Johnson syndrome and toxic epidermal necrolysis

    P Wolkenstein;O Chosidow;M L Fléchet;O Robbiola

  • Repair of the lower and middle parts of the face by composite tissue allotransplantation in a patient with massive plexiform neurofibroma: a 1-year follow-up study.

    Laurent Lantieri;Jean-Paul Meningaud;Philippe Grimbert;Frank Bellivier

  • Elevated risk for MPNST in NF1 microdeletion patients.

    T. De Raedt;H. Brems;P. Wolkenstein;D. Vidaud

  • Clinical characteristics of a series of 302 French patients with hidradenitis suppurativa, with an analysis of factors associated with disease severity.

    Florence Canoui-Poitrine;Florence Canoui-Poitrine;Jean E. Revuz;Pierre Wolkenstein;Cédric Viallette

  • Prognostic factors of CNS tumours in Neurofibromatosis 1 (NF1): a retrospective study of 104 patients.

    Jean-Sébastien Guillamo;Alain Créange;Chantal Kalifa;Jacques Grill

  • Association between benign and malignant peripheral nerve sheath tumors in NF1.

    T. Tucker;P. Wolkenstein;J. Revuz;J. Zeller

  • Combination therapy with clindamycin and rifampicin for hidradenitis suppurativa: a series of 116 consecutive patients.

    G. Gener;F. Canoui-Poitrine;J.E. Revuz;O. Faye

  • Open trial of ciclosporin treatment for Stevens-Johnson syndrome and toxic epidermal necrolysis.

    L. Valeyrie-Allanore;P. Wolkenstein;L. Brochard;N. Ortonne

  • Neurological complications of neurofibromatosis type 1 in adulthood.

    A. Créange;J. Zeller;S. Rostaing-Rigattieri;P. Brugières

  • Cardiovascular malformations and other cardiovascular abnormalities in neurofibromatosis 1.

    Angela E. Lin;Patricia H. Birch;Bruce R. Korf;Romano Tenconi

  • Identification of Three Hidradenitis Suppurativa Phenotypes: Latent Class Analysis of a Cross-Sectional Study

    Florence Canoui-Poitrine;Aurélie Le Thuaut;Jean E Revuz;Cédric Viallette

  • Pulmonary complications in toxic epidermal necrolysis: a prospective clinical study

    F. Lebargy;P. Wolkenstein;M. Gisselbrecht;F. Lange

  • NF1 microdeletions in neurofibromatosis type 1: from genotype to phenotype†

    Eric Pasmant;Audrey Sabbagh;Gillian Spurlock;Ingrid Laurendeau

Frequent Co-Authors

Olivier Chosidow
Olivier Chosidow Université Paris Cité
Jean Revuz
Jean Revuz Université Paris Cité
Martine Bagot
Martine Bagot Université Paris Cité
Jean-Claude Roujeau
Jean-Claude Roujeau Université Paris Cité
Nicolas Dupin
Nicolas Dupin Université Paris Cité
Ivan Bièche
Ivan Bièche Institute Curie
Bernard Grandchamp
Bernard Grandchamp Université Paris Cité
Céleste Lebbé
Céleste Lebbé Hôpitaux Universitaires Paris-Ouest
Christian Brun-Buisson
Christian Brun-Buisson Institut Pasteur
Jean-Jacques Grob
Jean-Jacques Grob Aix-Marseille University

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

While studying Medicine in the USA remains highly competitive, there are many related online degrees and career pathways that offer versatility and accessible entry points into healthcare. These programs appeal to those seeking flexible, affordable alternatives or looking to specialize in the medical field without traditional medical school.

For those interested in pharmacy, online pharmd programs make it possible to earn an advanced pharmacy degree remotely—ideal for working professionals. Meanwhile, the rise of technology-driven healthcare is fueling demand for digital experts. Health informatics degrees focus on managing medical data and technology, paving the way for careers at the intersection of healthcare and IT.

Entry-level programs like billing and coding classes online prepare students for specialized roles supporting healthcare administration. These courses are often short and lead to quickly employable certifications.

Those seeking advanced clinical roles can explore affordable np programs, which train registered nurses to become nurse practitioners with expanded responsibilities and autonomy.

Best Scientists Citing Pierre Wolkenstein

Trending Scientists